Arkansas Financial Group’s iShares US Medical Devices ETF IHI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.8M | Buy |
192,713
+1,842
| +1% | +$113K | 1.83% | 16 |
|
|
2025
Q1 | $10.7M | Buy |
190,871
+7,603
| +4% | +$425K | 1.84% | 14 |
|
|
2024
Q4 | $10.7M | Buy |
183,268
+5,172
| +3% | +$302K | 1.73% | 15 |
|
|
2024
Q3 | $10.5M | Sell |
178,096
-2,594
| -1% | -$154K | 1.73% | 13 |
|
|
2024
Q2 | $10.1M | Buy |
180,690
+1,443
| +0.8% | +$80.9K | 1.8% | 12 |
|
|
2024
Q1 | $10.5M | Buy |
179,247
+3,573
| +2% | +$209K | 1.85% | 12 |
|
|
2023
Q4 | $9.48M | Buy |
175,674
+13,656
| +8% | +$737K | 1.75% | 13 |
|
|
2023
Q3 | $7.86M | Buy |
162,018
+10,521
| +7% | +$510K | 1.6% | 15 |
|
|
2023
Q2 | $8.55M | Buy |
151,497
+1,703
| +1% | +$96.2K | 1.71% | 14 |
|
|
2023
Q1 | $8.09M | Sell |
149,794
-6,533
| -4% | -$353K | 1.68% | 15 |
|
|
2022
Q4 | $8.22M | Sell |
156,327
-41,159
| -21% | -$2.16M | 1.8% | 14 |
|
|
2022
Q3 | $9.32M | Buy |
197,486
+7,298
| +4% | +$344K | 2.21% | 13 |
|
|
2022
Q2 | $9.59M | Buy |
190,188
+14,782
| +8% | +$746K | 2.19% | 12 |
|
|
2022
Q1 | $10.7M | Buy |
175,406
+24,431
| +16% | +$1.49M | 2.21% | 13 |
|
|
2021
Q4 | $9.94M | Buy |
150,975
+39,285
| +35% | +$2.59M | 2% | 13 |
|
|
2021
Q3 | $7.01M | Buy |
111,690
+13,338
| +14% | +$837K | 1.54% | 15 |
|
|
2021
Q2 | $5.92M | Buy |
98,352
+12,510
| +15% | +$753K | 1.34% | 15 |
|
|
2021
Q1 | $4.73M | Buy |
85,842
+5,340
| +7% | +$294K | 1.13% | 16 |
|
|
2020
Q4 | $4.39M | Buy |
80,502
+17,868
| +29% | +$975K | 1.12% | 17 |
|
|
2020
Q3 | $3.13M | Buy |
62,634
+4,770
| +8% | +$238K | 0.92% | 17 |
|
|
2020
Q2 | $2.55M | Buy |
57,864
+9,714
| +20% | +$429K | 0.81% | 19 |
|
|
2020
Q1 | $1.81M | Buy |
48,150
+21,588
| +81% | +$811K | 0.67% | 19 |
|
|
2019
Q4 | $1.17M | Buy |
26,562
+6,228
| +31% | +$274K | 0.39% | 19 |
|
|
2019
Q3 | $838K | Buy |
20,334
+9,444
| +87% | +$389K | 0.3% | 21 |
|
|
2019
Q2 | $436K | Buy |
+10,890
| New | +$436K | 0.16% | 21 |
|